潘娜娜, 谭丽娟, 马建英, 孙志萍, 于希娟. Rho激酶在急性心肌梗死大鼠中的表达及其对心肌细胞凋亡的影响[J]. 心脏杂志, 2011, 23(1): 16-19.
    引用本文: 潘娜娜, 谭丽娟, 马建英, 孙志萍, 于希娟. Rho激酶在急性心肌梗死大鼠中的表达及其对心肌细胞凋亡的影响[J]. 心脏杂志, 2011, 23(1): 16-19.
    Expression of Rho-kinase in rats with acute myocardial infarction and its relationship to apoptosis[J]. Chinese Heart Journal, 2011, 23(1): 16-19.
    Citation: Expression of Rho-kinase in rats with acute myocardial infarction and its relationship to apoptosis[J]. Chinese Heart Journal, 2011, 23(1): 16-19.

    Rho激酶在急性心肌梗死大鼠中的表达及其对心肌细胞凋亡的影响

    Expression of Rho-kinase in rats with acute myocardial infarction and its relationship to apoptosis

    • 摘要: 目的: 分析心肌梗死(MI)后大鼠心肌组织中Rho激酶表达的变化,探讨Rho激酶信号通路与心肌细胞凋亡的关系及其选择性抑制剂法舒地尔对MI后心肌的保护作用。 方法: 选取雄性Wistar大鼠,结扎其左前降支建立急性心肌梗死(AMI)模型。将术后24 h存活的24只大鼠随机分为治疗组(n=12)和AMI组(n=12),另随机选取10只大鼠作为假手术组,只在其左前降支下穿线不结扎。治疗组腹腔注射法舒地尔5 mg/kg,每日两次;AMI组和假手术组给予等量的生理盐水。4周后,用Evens蓝及四唑氮蓝试验(NBT)双染确定缺血及梗死面积;用RT-PCR法测定Rho激酶mRNA的表达;DNA片段分析观察心肌细胞凋亡的情况;用免疫组化染色法测定凋亡相关蛋白bcl-2及bax表达的变化。结果: 与AMI组相比,治疗组的梗死面积显著减小(P<0.05)。AMI大鼠缺血心肌组织中DNA片段分析显示,有DNA梯状条带(ladder)形成,假手术组大鼠却没有。AMI组大鼠中Rho激酶mRNA及凋亡相关蛋白bax的表达明显增加(P<0.01,P<0.01);bcl-2的表达明显减少(P<0.01)。以法舒地尔治疗4周后,Rho激酶mRNA及bax的表达均显著减少,bcl-2的表达显著增加(均P<0.01)。结论: MI大鼠心肌组织中Rho激酶的表达升高,心肌细胞凋亡增加。法舒地尔能够减少Rho激酶的表达,减少心肌细胞凋亡,发挥对心肌的保护作用。

       

      Abstract: AIM: To analyze the changes of Rho-kinase expression in rats with acute myocardial infarction (AMI) and to study the relationship between cardiac myocyte apoptosis and Rho/Rock signaling pathway and the effect of fasudil, a Rho kinase selective inhibitor, on cardiac protection after AMI. METHODS: Male Wistar rats were subjected to left anterior descending coronary artery (LAD) ligation for 24 h and the surviving rats were randomly divided into two groups: treatment group (n=12) and AMI group (n=12). Another ten rats were randomly selected as the sham-operated group (n=10), with no ligation of LAD. Fasudil (5 mg/kg) was given to rats of the treatment group twice a day by IP injection. Rats of the AMI group and sham-operated group during the same period were given an equivalent normal of saline. Rats were sacrificed 4 weeks after and the infarct size and ischemia size were determined by Evans-blue and NBT double staining. The Rho kinase mRNA expression in the ischemia region was measured by RT-PCR and the apoptotic cardiocytes in the ischemia region were determined by DNA ladder analysis. Bcl-2 and Bax protein expressions were measured by immunohistochemical staining. RESULTS: Infarct size was obviously reduced in treatment group compared with AMI group (P<0.05) and no significant difference was observed in the ischemic area. The expression of Rho kinase increased significantly in AMI group compared with sham group. Expression of apoptosis-related protein and bax increased whereas bcl-2 decreased (P<0.01). Compared with those in AMI group, the expression of Rho kinase significantly attenuated, bax decreased and bcl-2 increased in the treatment group (P<0.01). DNA agarose gel electrophoresis of both AMI group and treatment group formed ladders, but no ladders were observed in sham group. CONCLUSION: In the myocardium of rats with AMI, the expression of Rho kinase and the apoptosis of myocardial cells are increased. Fasudil, a Rho kinase inhibitor, attenuates the expression of Rho kinase and apoptosis of myocardial cells and decreases infarct size, therefore playing an important role in cardiac protection after AMI.

       

    /

    返回文章
    返回